Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06576401
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-20
Brief Title:
A Study To Characterize Mass Balance Of 14C HDM1002 in Chinese Healthy Subjects
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase1 Study to Characterize Mass Balance Of 14C HDM1002 in Chinese Healthy Subjects
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study a single dose of 14C radiolabelled HDM1002 will be administered orally The main purpose of this study is to find out how much of HDM1002 and its metabolites pass from blood into urine and feces and characterize the metabolic profile and routes of excretion of oral 14C HDM002
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None